Search

Twist Bioscience Corp

Gesloten

SectorGezondheidszorg

117.97 -5.84

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

117.97

Max

124.48

Belangrijke statistieken

By Trading Economics

Inkomsten

9M

-35M

Verkoop

7.7M

118M

EPS

-0.56

Winstmarge

-29.61

Werknemers

979

EBITDA

9.8M

-28M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

-12.3% downside

Dividenden

By Acuity

Volgende Winsten

13 nov 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

1.5B

7.8B

Vorige openingsprijs

123.81

Vorige sluitingsprijs

117.97

Nieuwssentiment

By Acuity

50%

50%

163 / 340 Rangschikking in Healthcare

Twist Bioscience Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

14 aug 2026, 19:06 UTC

Twist Bioscience shares are lower today, continuing a decline since Thursday amid broader market volatility and recent U.S. retail sales data.

13 aug 2026, 23:06 UTC

Correlated Moves

Twist Bioscience Corp shares are lower in after-market trading, influenced by broader market declines and recent macroeconomic data on jobless claims and producer prices.

12 aug 2026, 19:16 UTC

Twist Bioscience Corp is higher Wednesday, tracking broader U.S. stock gains amid strength in AI sectors following positive quarterly results from CoreWeave and Super Micro Computer.

11 aug 2026, 23:46 UTC

Correlated Moves

Twist Bioscience Corp shares declined during after-market hours, following a drop in the Russell 2000 Index amid investor caution ahead of the consumer price index report.

10 aug 2026, 20:03 UTC

News
Social Media

Twist Bioscience Corp shares are higher today, buoyed by positive social media sentiment and a notable increase in trading volume since Friday's close.

7 aug 2026, 19:51 UTC

Twist Bioscience Corp shares are higher during Friday's session, with strong market activity and unusually high volume. No specific news explains this movement.

6 aug 2026, 22:56 UTC

Twist Bioscience Corp shares are higher in after-market trading, reflecting positive momentum since Thursday's close amid broader economic data indicating labor market strength.

5 aug 2026, 23:56 UTC

Twist Bioscience Corp shares rose in after-market trading, despite earlier declines. Market sentiment was affected by a disappointing ADP employment report.

4 aug 2026, 23:01 UTC

News

Twist Bioscience announced a $250 million public offering, raising concerns over potential dilution. Shares are trading lower in after-market hours following the announcement.

3 aug 2026, 22:16 UTC

Twist Bioscience Corp shares are lower in after-market hours, despite an initial gain following Monday's close. No specific news was identified to explain the decline.

31 jul 2026, 19:56 UTC

Twist Bioscience shares are higher, reflecting positive sentiment in biotechnology amid strong results from major technology firms like Amazon.

30 jul 2026, 10:16 UTC

Twist Bioscience Corp is trading slightly higher in pre-market hours, recovering from a decline in the previous session amid broader tech stock volatility.

29 jul 2026, 19:36 UTC

Correlated Moves
Macro Event

Twist Bioscience shares are lower today, influenced by a declining Russell 2000 Index and persistent inflation concerns amid steady interest rates.

28 jul 2026, 21:56 UTC

Twist Bioscience Corp shares are trading lower in after-market hours. Broader market trends, including declines in Asian semiconductor stocks, may be influencing this movement.

27 jul 2026, 19:33 UTC

Twist Bioscience Corp shares are lower today, continuing a recent downward trend. The stock pulled back significantly after reaching a session high.

24 jul 2026, 15:24 UTC

Twist Bioscience Corp shares are lower today, reversing a recent trend of gains. High trading volume accompanies the decline amid mixed economic signals.

21 jul 2026, 20:02 UTC

Correlated Moves

Twist Bioscience Corp is advancing today, supported by high trading volume and renewed investor interest in technology and AI stocks, despite a pullback earlier in the session.

20 jul 2026, 23:06 UTC

Twist Bioscience Corp shares are higher in after-market trading, though no specific news was identified to explain the movement. The stock remains below its 20-day moving average.

Peer Vergelijking

Prijswijziging

Twist Bioscience Corp Prognose

Koersdoel

By TipRanks

-12.3% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 109.88 USD  -12.3%

Hoogste 120 USD

Laagste 95 USD

Gebaseerd op 9 Wall Street-analisten die 12-maands prijsdoelen bieden voor Twist Bioscience Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

9 ratings

8

Buy

1

Hold

0

Sell

Sentiment

By Acuity

163 / 340 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
help-icon Live chat